potentially

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed with no safety or tolerability issues observed, allowing…

2 weeks ago

Securities Fraud Investigation Into MoonLake Immunotherapeutics (MLTX) Announced Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ:…

3 weeks ago

Securities Fraud Investigation Into Molina Healthcare, Inc. (MOH) Announced Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Molina Healthcare, Inc. (“Molina” or the “Company”)…

4 months ago

Zero Trust Security Reduces Cyber Insurance Claims, Preventing up to $465 Billion Annually in Global Economic Loss from Cyber Attacks

Nearly a third of the cyber events encompassed by the study potentially could have been prevented if zero trust was…

5 months ago

Colt, Honeywell and Nokia join forces to trial space-based quantum-safe cryptography

Press ReleaseColt, Honeywell and Nokia join forces to trial space-based quantum-safe cryptography Tech collaboration will explore ways to protect encrypted…

5 months ago